Font size
WorksheetsPharm 3 Chart
Total questions: 12
Worksheet time: 8mins
Risk of hypoglecemia
Metformin
Sulfonylureas
Insulin
DPP-4 Inhibitors
GLP-1 RA
Weight gain
SGLT-2 inhibitors
GLP 1 RA
TZDs
Sulfonylureas
Insulin
Weight loss
SGLT-2 Inhibitors
GLP-1 RAs
DPP-4 inhibitors
TZDs
Sulfonylureas
Association with HF Benefits
Metformin
SGLT 2 inhibitor
DPP-4 inhibitor
TZD
Sulfonylureas
Which of the following SGLT-2s have ASCVD benefits
Empagliflozin
Canagliflozin
Ertugliflozin
Dapagliflozin
GLP-1s with benefit for ASCVDs
Exanatide
Dulaglutide
Liraglutide
Semaglutide
Lixisenatide
Which of the following classes have no ASCVD benefits
SGLT-2 inhibitors
GLP-1 RA
DPP-4 inhibitors
Sulfonylureas
Insulin
Select the High cost classes
Metformin
SGLT-2 inhib
GLP-1 RA
DPP-4 inhib
TZD
Which of the following have drugs in their class that have renal benefits and require dose adjustments
DPP-4 inhibitors
SGLT-2 inhibitors
TZDs
Sulfonylureas
GI side effects and Potential for B12 deficiency seen in
SGLT-2 inhibitors
DPP-4 inhibitors
Metformin
TZDs
Black box warning of thyroid t-cell tumors in rodents seen in what class
DPP-4 inhibitors
TZDs
Sulfonylurea
GLP-1 RAs
Which class has an FDA black box warning associated with Congestive heart failure
TZD
DPP-4 inhibitors
Sulfonylureas
Insulin
